Billionaire Profile
Zhong Huijuan
Global Rank
#113

Image: Public domain | via Wikimedia Commons

Zhong Huijuan

CEO, Hansoh Pharmaceutical Group
CN
Real-Time Net Worth
$21.5B
As of December 2025
Age
64
Source
Pharmaceuticals
Industry
healthcare
Citizenship
CN

Biography

Zhong Huijuan is a prominent figure in the pharmaceutical industry and is celebrated as the world's richest self-made woman. Born in Lianyungang, Jiangsu Province, China, she completed her chemistry studies at Jiangsu Normal University in 1982. Zhong embarked on a career as a chemistry teacher before transitioning to the business world. In 1995, she founded Hansoh Pharmaceutical Group, where she currently serves as the CEO and Chair. Her source of wealth stems from the Pharmaceuticals industry. Through strategic vision and leadership, Zhong has transformed Hansoh into a leading pharmaceutical company, with a net worth of $21.5 billion in 2024. Hansoh's success is marked by significant investments in research and development, contributing to its diverse portfolio of drugs. Zhong's career highlights her journey from a chemistry teacher to a billionaire entrepreneur.

Wealth Over Time

In-Depth Profile

Early Life

Zhong Huijuan was born in April 1961, in Lianyungang, Jiangsu Province, China. She pursued her education at Jiangsu Normal University, graduating in July 1982, with a degree in chemistry. Following her graduation, Zhong started her career as a chemistry teacher at Yan'an Middle School in Lianyungang.

Rise to Success

In 1995, Zhong Huijuan co-founded Hansoh Pharmaceutical Group, initially with about ten employees. Her husband, Sun Piaoyang, was managing a state-owned pharmaceutical factory at the time, but he was unable to manage the new company, and Zhong stepped in to run the company. Zhong's leadership was instrumental in the company's rapid growth, with sales reaching $4.5 million by 1997. She is the majority shareholder, with a 66% stake. Hansoh Pharmaceutical had its initial public offering on the Hong Kong Stock Exchange in June 2019, raising US$1 billion. By 2019, Zhong became the richest self-made woman in Asia, with a net worth of US$10.5 billion. Zhong's wealth significantly increased in 2020 amid the COVID-19 pandemic.

Key Business Strategies

Zhong’s strategic focus and significant investment in research and development set Hansoh apart. The company's revenue from innovative drugs accounted for 82.7% of its total revenue in the first half of 2025. Hansoh has also secured multiple licensing deals with major pharmaceutical companies like Roche, GSK, Merck, and Regeneron. Hansoh has maintained a high R&D expenditure, with approximately 19.4% of its revenue allocated to R&D in the first half of 2025.

Philanthropy

The available sources do not have specific details on Zhong Huijuan's philanthropy. However, Hansoh Pharma's commitment to improving human health through innovation suggests a focus on initiatives related to healthcare and disease treatment.

Career Milestones

1982

Graduated

Graduated from Jiangsu Normal University with a degree in Chemistry

1995

Founded Hansoh Pharmaceutical

Co-founded Hansoh Pharmaceutical Group

2019

IPO

Hansoh Pharmaceutical went public on the Hong Kong Stock Exchange

2019

Richest Self-Made Woman in Asia

Became the richest self-made woman in Asia